November 14, 2025 · Form 4 insider transaction
DOYLE THOMAS JAMES sold 4,539 shares of Kura Oncology, Inc. at $11.18 per share, a transaction worth $50.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Sell-to-cover for taxes associated with the vesting of 1/6th of the underlying shares of performance-based restricted stock units ("PSUs") granted to the Reporting Person on May 31, 2023. Each PSU represents the contingent right to receive one share of the Issuer's common stock based on the achievement of each of three specified development milestones, and the one-year anniversary of each milestone achievement, subject to the Reporting Person's continuous service on each corresponding vesting date. The performance criteria for one specified development milestone was determined to be met on November 13, 2025, resulting in the vesting of 1/6th of the underlying shares.